Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Computed Tomography | Research

Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules

Authors: Hai-Cheng Zhao, Qing-Song Xu, Yi-Bing Shi, Xi-Juan Ma

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

There is a lack of clinical-radiological predictive models for the small (≤ 20 mm) solitary pulmonary nodules (SPNs). We aim to establish a clinical-radiological predictive model for differentiating malignant and benign small SPNs.

Materials and methods

Between January 2013 and December 2018, a retrospective cohort of 250 patients with small SPNs was used to construct the predictive model. A second retrospective cohort of 101 patients treated between January 2019 and December 2020 was used to independently test the model. The model was also compared to two other models that had previously been identified.

Results

In the training group, 250 patients with small SPNs including 156 (62.4%) malignant SPNs and 94 (37.6%) benign SPNs patients were included. Multivariate logistic regression analysis indicated that older age, pleural retraction sign, CT bronchus sign, and higher CEA level were the risk factors of malignant small SPNs. The predictive model was established as: X = − 10.111 + [0.129 × age (y)] + [1.214 × pleural retraction sign (present = 1; no present = 0)] + [0.985 × CT bronchus sign (present = 1; no present = 0)] + [0.21 × CEA level (ug/L)]. Our model had a significantly higher region under the receiver operating characteristic (ROC) curve (0.870; 50% CI: 0.828–0.913) than the other two models.

Conclusions

We established and validated a predictive model for estimating the pre-test probability of malignant small SPNs, that can help physicians to choose and interpret the outcomes of subsequent diagnostic tests.
Literature
1.
go back to reference Cruickshank A, Stieler G, Ameer F. Evaluation of the solitary pulmonary nodule. Intern Med J. 2019;49:306–15.CrossRef Cruickshank A, Stieler G, Ameer F. Evaluation of the solitary pulmonary nodule. Intern Med J. 2019;49:306–15.CrossRef
2.
go back to reference Chan EY, Gaur P, Ge Y, et al. Management of the solitary pulmonary nodule. Arch Pathol Lab Med. 2017;141:927–31.CrossRef Chan EY, Gaur P, Ge Y, et al. Management of the solitary pulmonary nodule. Arch Pathol Lab Med. 2017;141:927–31.CrossRef
3.
go back to reference Truong MT, Ko JP, Rossi SE, et al. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014;34:1658–79.CrossRef Truong MT, Ko JP, Rossi SE, et al. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014;34:1658–79.CrossRef
4.
go back to reference Nasim F, Ost DE. Management of the solitary pulmonary nodule. Curr Opin Pulm Med. 2019;25:344–53.CrossRef Nasim F, Ost DE. Management of the solitary pulmonary nodule. Curr Opin Pulm Med. 2019;25:344–53.CrossRef
5.
go back to reference Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348:2535–42.CrossRef Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348:2535–42.CrossRef
6.
go back to reference Majid A, Fernandez-Bussy S, Folch E. Interventional pulmonology and solitary pulmonary nodule. Arch Bronconeumol. 2018;54:497–8.CrossRef Majid A, Fernandez-Bussy S, Folch E. Interventional pulmonology and solitary pulmonary nodule. Arch Bronconeumol. 2018;54:497–8.CrossRef
7.
go back to reference Bonetti A, Aubert JD. Le nodule pulmonaire solitaire [The solitary pulmonary nodule]. Rev Med Suisse. 2008;4:2506–10.PubMed Bonetti A, Aubert JD. Le nodule pulmonaire solitaire [The solitary pulmonary nodule]. Rev Med Suisse. 2008;4:2506–10.PubMed
8.
go back to reference Kanai R, Tane K, Ishii G, et al. Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer. Jpn J Clin Oncol. 2018;48:1083–7.CrossRef Kanai R, Tane K, Ishii G, et al. Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer. Jpn J Clin Oncol. 2018;48:1083–7.CrossRef
9.
go back to reference Harzheim D, Eberhardt R, Hoffmann H, et al. The solitary pulmonary nodule. Respiration. 2015;90:160–72.CrossRef Harzheim D, Eberhardt R, Hoffmann H, et al. The solitary pulmonary nodule. Respiration. 2015;90:160–72.CrossRef
10.
go back to reference MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology. 2017;284:228–43.CrossRef MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology. 2017;284:228–43.CrossRef
11.
go back to reference Zhang ZD, Wang HL, Liu XY, et al. Methylene blue versus coil-based computed tomography-guided localization of lung nodules. Thorac Cardiovasc Surg. 2020;68:540–4.CrossRef Zhang ZD, Wang HL, Liu XY, et al. Methylene blue versus coil-based computed tomography-guided localization of lung nodules. Thorac Cardiovasc Surg. 2020;68:540–4.CrossRef
12.
go back to reference Fu YF, Li GC, Xu QS, et al. Computed tomography-guided lung biopsy: a randomized controlled trial of low-dose versus standard-dose protocol. Eur Radiol. 2020;30:1584–92.CrossRef Fu YF, Li GC, Xu QS, et al. Computed tomography-guided lung biopsy: a randomized controlled trial of low-dose versus standard-dose protocol. Eur Radiol. 2020;30:1584–92.CrossRef
13.
go back to reference Li Y, Wang T, Fu YF, et al. Computed tomography-guided biopsy for sub-centimetre lung nodules: technical success and diagnostic accuracy. Clin Respir J. 2020;14:605–10.CrossRef Li Y, Wang T, Fu YF, et al. Computed tomography-guided biopsy for sub-centimetre lung nodules: technical success and diagnostic accuracy. Clin Respir J. 2020;14:605–10.CrossRef
14.
go back to reference Liu GS, Wang SQ, Liu HL, et al. Computed tomography-guided biopsy for small (≤ 20 mm) lung nodules: a meta-analysis. J Comput Assist Tomogr. 2020;44:841–6.CrossRef Liu GS, Wang SQ, Liu HL, et al. Computed tomography-guided biopsy for small (≤ 20 mm) lung nodules: a meta-analysis. J Comput Assist Tomogr. 2020;44:841–6.CrossRef
15.
go back to reference Li Y, Chen KZ, Wang J. Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin Lung Cancer. 2011;12:313–9.CrossRef Li Y, Chen KZ, Wang J. Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin Lung Cancer. 2011;12:313–9.CrossRef
16.
go back to reference Xiao F, Liu D, Guo Y, et al. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors. PLoS ONE. 2013;8:e78271.CrossRef Xiao F, Liu D, Guo Y, et al. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors. PLoS ONE. 2013;8:e78271.CrossRef
17.
go back to reference Li Y, Chen KZ, Sui XZ, et al. Establishment of a mathematical prediction model to evaluate the probability of malignancy or benign in patients with solitary pulmonary nodules. Beijing Da Xue Xue Bao Yi Xue Ban. 2011;43:450–4.PubMed Li Y, Chen KZ, Sui XZ, et al. Establishment of a mathematical prediction model to evaluate the probability of malignancy or benign in patients with solitary pulmonary nodules. Beijing Da Xue Xue Bao Yi Xue Ban. 2011;43:450–4.PubMed
18.
go back to reference Li GC, Fu YF, Cao W, et al. Computed tomography-guided percutaneous cutting needle biopsy for small (≤ 20 mm) lung nodules. Medicine (Baltimore). 2017;96:e8703.CrossRef Li GC, Fu YF, Cao W, et al. Computed tomography-guided percutaneous cutting needle biopsy for small (≤ 20 mm) lung nodules. Medicine (Baltimore). 2017;96:e8703.CrossRef
19.
go back to reference Hu H, Wang Q, Tang H, et al. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign. Thorac Cancer. 2016;7:80–7.CrossRef Hu H, Wang Q, Tang H, et al. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign. Thorac Cancer. 2016;7:80–7.CrossRef
20.
go back to reference She Y, Zhao L, Dai C, et al. Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: a multi-institutional study. J Surg Oncol. 2017;116:756–62.CrossRef She Y, Zhao L, Dai C, et al. Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: a multi-institutional study. J Surg Oncol. 2017;116:756–62.CrossRef
21.
go back to reference Wang X, Xu YH, Du ZY, et al. Risk factor analysis of the patients with solitary pulmonary nodules and establishment of a prediction model for the probability of malignancy. Zhonghua Zhong Liu Za Zhi. 2018;40:115–20.PubMed Wang X, Xu YH, Du ZY, et al. Risk factor analysis of the patients with solitary pulmonary nodules and establishment of a prediction model for the probability of malignancy. Zhonghua Zhong Liu Za Zhi. 2018;40:115–20.PubMed
22.
go back to reference Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc. 1999;74:319–29.CrossRef Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc. 1999;74:319–29.CrossRef
23.
go back to reference Chen XB, Yan RY, Zhao K, et al. Nomogram for the prediction of malignancy in small (8–20 mm) indeterminate solid solitary pulmonary nodules in Chinese Populations. Cancer Manag Res. 2019;11:9439–48.CrossRef Chen XB, Yan RY, Zhao K, et al. Nomogram for the prediction of malignancy in small (8–20 mm) indeterminate solid solitary pulmonary nodules in Chinese Populations. Cancer Manag Res. 2019;11:9439–48.CrossRef
24.
go back to reference Zhao TJ, Zheng B. CT features and differential diagnosis of peripheral lung cancer and inlfammatory pseudotumor. Chin J CT and MRI. 2021;19:62–4. Zhao TJ, Zheng B. CT features and differential diagnosis of peripheral lung cancer and inlfammatory pseudotumor. Chin J CT and MRI. 2021;19:62–4.
25.
go back to reference Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.CrossRef Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.CrossRef
26.
go back to reference Li Y, Sui X, Yang D. Solitary pulmonary nodules: a risk factor analysis. Chin J Thoracic Cardiovasc Surg. 2010;26:161–4. Li Y, Sui X, Yang D. Solitary pulmonary nodules: a risk factor analysis. Chin J Thoracic Cardiovasc Surg. 2010;26:161–4.
27.
go back to reference Cui Y, Ma D, Yang J. The value of pleural indentation in the diagnosis of pulmonary nodule: a meta-analysis. J Cap Med Univ. 2007;28:709–12. Cui Y, Ma D, Yang J. The value of pleural indentation in the diagnosis of pulmonary nodule: a meta-analysis. J Cap Med Univ. 2007;28:709–12.
28.
go back to reference Ma YH, Li YX, Fang Y. A comparative study on pathology and CT signs of small peripheral lung cancer. Chin J Mod Med. 2013;23:100–3. Ma YH, Li YX, Fang Y. A comparative study on pathology and CT signs of small peripheral lung cancer. Chin J Mod Med. 2013;23:100–3.
29.
go back to reference Bates SE. Clinical applications of serum tumor markers. Ann Intern Med. 1991;15:623–38.CrossRef Bates SE. Clinical applications of serum tumor markers. Ann Intern Med. 1991;15:623–38.CrossRef
31.
go back to reference Bekci TT, Senol T, Maden E. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19–9 (CA19-9), carbohydrate antigen 15–3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. J Int Med Res. 2009;37:438–45.CrossRef Bekci TT, Senol T, Maden E. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19–9 (CA19-9), carbohydrate antigen 15–3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. J Int Med Res. 2009;37:438–45.CrossRef
Metadata
Title
Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules
Authors
Hai-Cheng Zhao
Qing-Song Xu
Yi-Bing Shi
Xi-Juan Ma
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01651-y

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.